Effects of stepwise lipid-controlled enteral nutrition on lipids and nutrition in hyperlipidemic acute pancreatitis with colorectal cancer

doi:10.4251/wjgo.121749

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 10

This Article

(8)

(0)

(60)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.

World J Gastrointest Oncol. Oct 15, 2026; 18(10): 121749
Published online Oct 15, 2026. doi: 10.4251/wjgo.121749

Table 1 Comparison of general data between the two groups, n (%) or mean ± SD

Project	Category	Control group (n = 50)	Observation group (n = 50)	t/χ² value	P value
Age (year)		58.20 ± 10.45	57.62 ± 11.34	0.266	0.791
Gender	Male	32 (64.00)	28 (56.00)	0.667	0.414
	Female	18 (36.00)	22 (44.00)
BMI (kg/m²)		26.80 ± 3.49	27.10 ± 3.20	-0.445	0.657
Severity of the condition	Mild cases	10 (20.00)	11 (22.00)	-0.162	0.922
	Moderate to severe	28 (56.00)	26 (52.00)
	Severe	12 (24.00)	13 (26.00)
Pathological nature	Benign	15 (30.00)	17 (34.00)	0.184	0.668
	Malignant	35 (70.00)	33 (66.00)
Diabetes	No	32 (64.00)	30 (60.00)	0.170	0.680
	Yes	18 (36.00)	20 (40.00)

BMI: Boda mass index.

Full Size Table

Table 2 Comparison of triglyceride levels before and after intervention in the two groups (n = 50), mean ± SD

Group	Before nutritional support (mmol/L)	Day 3 after nutritional support (mmol/L)	Day 7 after nutritional support (mmol/L)
Control group	17.24 ± 3.09	12.61 ± 2.58^a	7.58 ± 2.16^a^,^b
Observation group	17.59 ± 3.57	7.29 ± 2.37^a	4.75 ± 1.14^a^,^b
F value	0.278	115.284	66.797
P value	0.599	< 0.001	< 0.001

^aP < 0.05 vs before nutritional support.

^bP < 0.05 vs day 3 after nutritional support.

Full Size Table

Table 3 Comparison of total cholesterol, high-density lipoprotein cholesterol and low-density lipoprotein cholesterol levels before and after intervention in the two groups (n = 50), mean ± SD

Group		TC (mmol/L)	HDL-C (mmol/L)	LDL-C (mmol/L)
Control group	Before nutritional support	3.38 ± 0.59	0.72 ± 0.19	2.41 ± 0.54
	Day 3 after nutritional support	3.44 ± 0.51	0.64 ± 0.22	2.17 ± 0.47^a
	Day 7 after nutritional support	3.86 ± 0.56^a^,^b	0.96 ± 0.32^a^,^b	2.84 ± 0.49^a^,^b
Observation group	Before nutritional support	3.27 ± 0.50	0.75 ± 0.23	2.56 ± 0.42
	Day 3 after nutritional support	3.54 ± 0.46^a	0.87 ± 0.25^a^,^c	2.38 ± 0.35^a^,^c
	Day 7 after nutritional support	4.19 ± 0.54^a^,^b^,^c	1.28 ± 0.37^a^,^b^,^c	3.27 ± 0.42^a^,^b^,^c

^aP < 0.05 vs before nutritional support.

^bP < 0.05 vs day 3 after nutritional support.

^cP < 0.05 vs the control group at the same time point.

TC: Total cholesterol; HDL-C: High-density lipoprotein cholesterol; LDL-C: Low-density lipoprotein cholesterol.

Full Size Table

Table 4 Comparison of arm muscle circumference, albumin, prealbumin and transferrin levels before and after intervention in the two groups (n = 50), mean ± SD

Group		ALB (g/L)	PA (mg/L)	TRF (g/L)	AMC (cm)
Control group	Before nutritional support	31.52 ± 3.27	180.46 ± 23.66	1.68 ± 0.31	20.84 ± 2.52
	Day 3 after nutritional support	32.26 ± 2.93	192.53 ± 24.06^a	1.70 ± 0.25^a	20.68 ± 2.75
	Day 7 after nutritional support	35.28 ± 2.68^a^,^b	228.15 ± 27.43^a^,^b	1.86 ± 0.26^a^,^b	21.14 ± 2.30
Observation group	Before nutritional support	30.85 ± 3.54	181.52 ± 26.77	1.65 ± 0.28	21.21 ± 1.98
	Day 3 after nutritional support	33.86 ± 3.06^a^,^c	214.37 ± 27.93^a^,^c	1.76 ± 0.24^a^,^c	21.61 ± 2.15
	Day 7 after nutritional support	38.26 ± 2.83^a^,^b^,^c	251.74 ± 31.65^a^,^b^,^c	2.14 ± 0.28^a^,^b^,^c	22.29 ± 2.36^c

^aP < 0.05 vs before nutritional support.

^bP < 0.05 vs day 3 after nutritional support.

^cP < 0.05 vs the control group at the same time point.

ALB: Albumin; PA: Prealbumin; TRF: Transferrin; AMC: Arm muscle circumference.

Full Size Table

Table 5 Comparison of clinical symptom improvement before and after intervention in the two groups (n = 50), mean ± SD

Group	Abdominal pain relief time (day)	Time to relief of abdominal bloating symptoms (day)	Length of hospital stay (day)
Control group	5.3 ± 1.2	6.6 ± 1.5	14.6 ± 3.7
Observation group	3.8 ± 0.9	4.8 ± 1.3	12.4 ± 2.6
t value	6.685	6.406	3.437
P value	< 0.001	< 0.001	0.001

Full Size Table

Table 6 Comparison of complication rates between the two groups, n (%)

Group	Total	Malnutrition	Diarrhea	Infect	Enterocutaneous fistula	Total occurrence
Control group	50	6 (12.00)	4 (8.00)	6 (12.00)	2 (4.00)	18 (36.00)
Observation group	50	0	2 (4.00)	3 (6.00)	1 (2.00)	6 (12.00)
χ² value						7.895
P value						0.005

Full Size Table

Citation: Chen P, Dai XC, Qin HM. Effects of stepwise lipid-controlled enteral nutrition on lipids and nutrition in hyperlipidemic acute pancreatitis with colorectal cancer. World J Gastrointest Oncol 2026; 18(10): 121749
URL: https://www.wjgnet.com/1948-5204/full/v18/i10/121749.htm
DOI: https://dx.doi.org/10.4251/wjgo.121749

Chen P, Dai XC, Qin HM. Effects of stepwise lipid-controlled enteral nutrition on lipids and nutrition in hyperlipidemic acute pancreatitis with colorectal cancer. World J Gastrointest Oncol 2026; 18(10): 121749 [DOI: 10.4251/wjgo.121749]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.